Glaukos Corp. (GKOS)
237.60
-4.88
(-2.01%)
USD |
NYSE |
Oct 30, 16:00
237.58
-0.02
(-0.01%)
After-Hours: 20:00
Glaukos Free Cash Flow : 19.41M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 19.41M |
| June 30, 2026 | -28.80M |
| March 31, 2026 | -35.09M |
| December 31, 2025 | -39.06M |
| September 30, 2025 | -27.61M |
| June 30, 2025 | -26.92M |
| March 31, 2025 | -53.24M |
| December 31, 2024 | -67.62M |
| September 30, 2024 | -81.27M |
| June 30, 2024 | -81.76M |
| March 31, 2024 | -75.17M |
| December 31, 2023 | -78.01M |
| September 30, 2023 | -75.48M |
| June 30, 2023 | -96.51M |
| March 31, 2023 | -104.19M |
| December 31, 2022 | -63.35M |
| September 30, 2022 | -64.97M |
| June 30, 2022 | -24.54M |
| March 31, 2022 | -6.903M |
| December 31, 2021 | -23.08M |
| September 30, 2021 | -0.64M |
| June 30, 2021 | -19.36M |
| Date | Value |
|---|---|
| March 31, 2021 | -29.05M |
| December 31, 2020 | -29.92M |
| September 30, 2020 | -43.77M |
| June 30, 2020 | -36.91M |
| March 31, 2020 | -18.53M |
| December 31, 2019 | -5.093M |
| September 30, 2019 | 9.838M |
| June 30, 2019 | 17.47M |
| March 31, 2019 | 15.99M |
| December 31, 2018 | 8.549M |
| September 30, 2018 | 9.024M |
| June 30, 2018 | 9.998M |
| March 31, 2018 | 9.667M |
| December 31, 2017 | 19.12M |
| September 30, 2017 | 10.33M |
| June 30, 2017 | 6.635M |
| March 31, 2017 | 8.911M |
| December 31, 2016 | 6.031M |
| September 30, 2016 | 3.85M |
| June 30, 2016 | 2.198M |
| March 31, 2016 | -3.131M |
| December 31, 2015 | -3.065M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Globus Medical, Inc. | 750.84M |
| Edwards Lifesciences Corp. | 1.434B |
| Becton, Dickinson & Co. | 2.533B |
| Merit Medical Systems, Inc. | 200.50M |
| Insulet Corp. | 265.70M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 38.57M |
| Cash from Investing (Quarterly) | -5.541M |
| Cash from Financing (Quarterly) | 14.68M |
| Free Cash Flow Per Share (Quarterly) | 0.5963 |
| Free Cash Flow to Equity (Quarterly) | 37.34M |
| Free Cash Flow to Firm (Quarterly) | 37.44M |
| Free Cash Flow Yield | 0.14% |